Mice and Fungal strains 6-10 weeks old female C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME). Clec7a -/-generated as previously described (16) were crossed 9 generations onto the C57BL/6J background. Progeny homozygous for Clec7a -/-and wildtype littermates aged 7-12 weeks were used where indicated. All animals were housed under specific pathogen-free conditions at the Cedars-Sinai Medical Center and experiments were performed after prior approval by the Institutional Animal Care and Use Committee at Cedars-Sinai Medical Center and conformed to the policies and procedures of the Comparative Medicine Department.
Candida tropicalis (ATCC 750) and Saccharomyces cerevisiae (ATCC 201388) were obtained directly from the American Type Culture Collection (Manassas, VA). Saccharomycopsis fibuligera was isolated directly from murine feces and identified by rDNA sequencing. Yeasts were cultured in aerobic conditions on Sabouraud Dextrose Broth (SDB; EMD Chemicals) at 37 o C.
In situ staining of intestinal fungi OCT-embedded intestinal specimens were sectioned, mounted on microscope slides and then incubated for 40 min in PBS containing 2% FCS. Murine soluble Dectin-1 (sDec-1) was generated and biotin-labeled as previously described (21) . sDec-1 (10 μg/ml) was fluorescently labeled with streptavidin-Alexa 647 (2 μg/ml, Invitrogen) (sDec-1-Alexa647), and intestinal sections were stained for 1hr. To block Dectin-1 interaction, sDec-1-Alexa647 was incubated with 1 μg/ml laminarin (soluble β-glucan from Laminaria digitata, Sigma) and intestinal sections were stained as previously described. Alternatively, intestinal sections were stained with FITC-conjugated rabbit anti-Candida polyclonal antibody (Meridian Life Science, Cincinnati, OH). We found that this "anti-Candida antibody" was cross-reactive with a wide variety of fungal species including C. tropicalis, C. albicans, S. cerevisiae, S. fibuligera and A. fumigatus, but did not stain bacteria (E. coli, C. jejuni, S. aureus). Therefore throughout this study we have referred to the antibody as an "anti-fungal antibody". Slides were rinsed with PBS and stained for 5 min with 0.1 µg/ml 4',6-diamidino-2-phenylindole (DAPI, Invitrogen) and overlaid with mounting medium (Vectashield; Vector, Burlingame, CA). Slides were examined using a Zeiss Axio Observer Fluorescence microscope. All compared images were collected and processed identically. Colons from Fluconazole (0.5 mg/ml for 2 weeks in the drinking water) treated mice were used in control staining.
Staining of fungi in the feces
Fecal pellets were collected, homogenized in PBS containing 2% FCS and filtered through a mesh to obtain homogeneous fecal suspensions. Fecal suspensions were stained for 1 hour with sDec-1-Alexa647, anti-fungal FITC-conjugated antibody and DAPI as previously described. Control suspensions were stained with laminarin blocked sDec-1-Alexa647, FITC-labeled rabbit-IgG-isotype control antibody and DAPI. Data were analyzed by flow cytometry. To visualize intestinal fungi bound to Dectin-1, fecal samples were stained with sDec-1-Alexa647, fixed in 4% formaldehyde and sorted using a FACSAria (BD Biosciences). Sorted fungal cells were viewed using a TCS SP5 laserscanning confocal microscope (Leica).
Detection of anti-Saccharomyces cerevisiae antibodies (ASCA)
For the induction of ASCA antibody responses to intestinal fungal antigens, mice were kept on 2.5% DSS supplemented water for 2 cycles of 7 days each. After each cycle mice were given regular water for 2 weeks. Then mice were sacrificed, blood was collected and blood serum was obtained. ELISA detection of ASCA specific IgM and IgG was carried out as previously described (26) . Samples were read at 405 nm on a Molecular Devices E-Max microtiter plate reader (Menlo Park, CA).
Candida killing assay
Intestinally conditioned dendritic cells (DCs) were prepared from WT and Clec7a -/-mice as previously described (27) . Candida tropicalis (1×10 5 ) was reuspended in RPMI 1640 supplemented with 5% fetal bovine serum (FBS) and added onto 1×10 5 DCs, and incubated at 37°C in a 5% CO 2 incubator for 1 hour. Wells were washed and fresh media containing fluconazole (300 μg/ml) was added. At 6 hours and 18 hours, DCs were washed three times with PBS, lysed in water, and C. tropicalis CFU were calculated by plating on SDB agar.
Induction of DSS colitis and histopathology
WT and Clec7a -/-mice were co-housed for three weeks prior the experiments. Alternatively, WT and Clec7a -/-littermates were used where indicated. For the induction of colitis, mice were given drinking water supplemented with 2.5% (w/v) Dextran sulphate sodium (DSS, MP Biomedicals, LLC, Aurora, OH) for 7 days and sacrificed at day 12. For ablation of intestinal fungi, mice were given Fluconazole (0.5 mg/ml, Sigma) in the drinking water for total of 14 days starting 2 days prior the induction of DSS colitis. In some experiments, prior and upon colitis induction, mice were supplemented every other day with four doses (1x10 8 yeast/mouse/dose) of Candida tropicalis or Saccharomycopsis fibuligera as shown in Supplementary Figure 18 .
Body weight, gross blood, and stool consistency were analyzed on a daily basis. Paraffin-embedded colon tissues were sectioned and stained with H&E for pathology assessment. Assessment of the severity of colitis was measured by the disease activity index (DAI) as previously described (28) .
Antibiotic treatment and microbiota reconstitution
For depletion of intestinal microbiota, mice were given an antibiotic cocktail, containing ampicillin (1 g/l; Sigma, St. Louis, MO), vancomycin (500 mg/l, Sigma), neomycin sulfate (1 g/l, Sigma), metronidazole (1 g/l, Sigma) and fluconazole (0.5 mg/ml, Sigma) in drinking water for 3 weeks. Fecal pellets were collected and tested for microbiota depletion by culture method (aerobic and anaerobic), sDec-1-Alexa647 staining (to evaluate depletion of fungi) and quantitative PCR. Microbiota-depleted mice were both, orally gavaged and intrarectally administrated with homogenates prepared from WT or Clec7a -/-feces, and 10 days after reconstitution DSS administration was started.
Isolation of intestinal mucosa, colonic cells and large intestine lamina propria (LI-LP) lymphocytes LI-LP lymphocytes were isolated as previously described (29) with some modifications. Briefly, colons were isolated, opened longitudinally, washed of fecal contents and then cut into 1 cm pieces. Intestinal pieces were transferred into HBSS medium (Sigma), supplemented with 5% fetal bovine serum (FBS) and 2 mM EDTA, and were shaken for 15 min at 37°C. The suspensions were filtered through a mesh and the filtrate containing the mucosa and mucosa-associated microflora was used further for DNA isolation. The remaining tissue was washed, cut in small pieces and subsequently incubated in digestion medium consisting of RPMI 1640, 5% FBS, 0.5 mg/ml collagenase type VIII (Sigma), 5 U/ml DNase (Roche Diagnostics), 100 IU/ml penicillin and 100 μg/ml streptomycin for 30 min at 37°C by gentle shaking. The cell suspensions were filtered through a mesh, and then centrifuged at 1300 rpm. Cell suspensions were cultured overnight and TNF-α production by colonic cells was measured by ELISA (BioLegend, San Diego, CA).
The rest of the pellets were resuspended in 6 ml of 40% Percoll (GE Healthcare BioSciences AB, Uppsala, Sweden), overlaid on 3 ml of 70% Percoll and centrifuged at 2000 rpm for 20 min at 25°C. The interface cells were collected and used as LI-LP lymphocytes.
Lymphocyte stimulation and cytokine analysis Cell suspensions were prepared from MLNs and the LI-LP as described above. Cells were incubated with 50 ng/ml phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich), 500 ng/ml ionomycin (Sigma-Aldrich) and 10 μg/ml Brefeldin A (BFA; Sigma-Aldrich) in complete RPMI media at 37° C for 6 h. After surface staining with CD4, cells were permeabilized and intracellular cytokine staining was performed using APC-labeled anti-IFN-γ mAb (XMG1.2; BD Biosciences) and PE-labeled anti-IL-17 mAb (TC11-18H10; BD Biosciences) according to the manufacturer's instructions. Flow cytometry was performed using a LSRII (BD Biosciences) and data were analyzed with FlowJo software (TreeStar Inc.).
For detection of cytokines by ELISA, MLN cells and LI-LP lymphocytes were stimulated with 10 μg/ml plate bound anti-CD3 and anti-CD28 antibodies (BioLegend, San Diego, CA). Supernatants were collected after 36 hrs and analyzed for IFN-γ and IL-17 production by ELISA (BioLegend, San Diego, CA).
DNA isolation, fungal and bacterial rDNA gene quantitative analysis
Intestinal mucosa from ileum, caecum, proximal and distal colon was obtained as described above. Feces were collected from non-treated or DSS treated C57BL/6J and Clec7a -/-mice. Additionally, feces were collected from BALB/c mice, 129S2/Sv mice, Rat, Guinea Pig, Pig, Rabbit and Dog, all breed and housed in the animal facility of Cedars-Sinai medical center. Human fecal samples from 3 healthy donors were collected after obtaining informed consent and immediately frozen. Fecal or mucosal samples were resuspended in 50 mM Tris buffer (pH7.5) containing 1 mM EDTA, 0.2% β-mercaptoethanol (Sigma) and 1000 U/ml of lyticase (Sigma). The mix was incubated at 37 o C for 30 min and fungal genomic DNA was isolated by using QIAamp DNA Stool Mini Kit (Qiagen) according to the manufacturer's instructions.
For evaluation of fungal rDNA in feces, 80 ng of total fecal DNA was used as a template for qPCR analysis. The following anti-fungal primers were used:
For detection of mucosa-associated fungi, quantitative PCR was performed on DNA isolated from intestinal mucosa using fungal-specific primers listed above. Relative quantity was calculated by the ΔCt method and normalized to the amount of β-actin (actb, for mucosal samples) or to the weight of the sample and the amount of total DNA used (for the fecal samples). The following β-actin (actb) primers were used: forward primer 5'-ATGACCCAGATCATGTTTGA-3' and reverse primer 5'-TACGACCAGAGGCATACAG-3'.
Microbiome sequencing analysis Mouse fungal and bacterial microbiomes were interrogated using Roche 454 and an Illumina GAIIxe next generation sequencing platforms. DNA was isolated from feces of co-housed or littermate mice before and after DSS treatment, and from a sample of food (Mouse Diet 5015; LabDiet, St. Louis, MO) using the protocol described above.
454 library generation and sequencing Fungal ITS1-2 regions were amplified by PCR using primers modified to include sample barcodes and sequencing adaptors (22) . DNA was amplified using the following PCR protocol: Initial denaturation at 94 o C for 10 min, followed by 40 cycles of denaturation at 94 o C for 30 s, annealing at 55 o C for 30 s, and elongation at 72 o C for 2 min, followed by an elongation step at 72 o C for 30 min. The PCR products containing ITS fungal regions were purified and subjected to emulsion PCR and pyrosequencing using a 454 GS FLX System (Roche Diagnostics GmbH/454 Life Sciences Corporation) at the UCLA Genotyping and Sequencing Core.
Illumina library generation Fecal DNA was amplified using the PCR protocol described above using the following primers (22) , (30):
ITS1-2 and Bacterial 16S amplicons were subjected to a modified TruSeq protocol (version 2). Unique duplexed primers containing paired end adapters and indexes were ligated to the 1 μg of ITS1-2 or 16S amplicons respectively. Library enrichment was performed with 10 cycles of PCR and purification was performed using Agencourt Ampure Magnetic Beads (Beckman). All libraries were subjected to quality control using qPCR, DNA 1000 Bioanalyzer (Agilent), and Qubit (Life Technologies) to validate and quantitate library construction prior to preparing a Paired End flow cell. Samples were randomly divided among flow cells to minimize sequencing bias. Clonal bridge amplification (Illumina) was performed using a cBot (Illumina). 100x150 bp sequencingby-synthesis was performed. At 150 bps, 89% of bps were above Q30, exceeding Illumina's standard sequence quality metric.
Data Analysis 454 data analysis: Raw sequence data were identified by their unique barcodes for each dataset and tabulated using QIIME (31);Unlike bacteria, the range of sequence divergence both between and within species of fungi may differ <3% in ITS-2 sequence, approaching the error rate of the 454 and making the delineation of sequence reads into OTUs less precise (32) .To avoid spurious OTU clustering using 454 data, we used an alternate approach to defining OTUs in which each unique sequence read was aligned to a previously described fungal ITS reference database (32) using BLAST (33) . A custom Perl script was then used to parse the alignment results to identify alignments with ≥ 98% identity over the entire sequence read. Reads failing to align at this stringent level were discarded. The alignment results were then tabulated across all reads, using the accession identifier of the ITS reference sequences as surrogate OTUs. Over 85% of our sequences aligned with at least 98% identity to a reference sequence, which corresponds well to both the 98% mapping cut-off previously used in the analysis of the fungal mycobiome (22) and to our own analysis of the complete dataset. Finally, the OTUs were manually curated to establish species names.
For Illumina bacterial and fungal analysis, because of the abundance of Illumina reads and higher overall sequence quality of the reads, we used the QIIME package with minimal customization. Bcl files were de-multiplexed using cassava (v1.8). qSeq files were converted to FASTA files for QIIME using SAMTOOLS (34) .QIIME was installed on a 400 node dual processor high performance cluster each with 4 GB of RAM. Each 150bp fungal sequence was then BLASTed against the reference database using blastn and a cut off for a 99% nt identity match (>148/150 bps). Each result was summed across unique GenBank accession numbers. For bacterial biome analysis, 150bp single end reads from each sample were collapsed into OTUs using UCLUST and annotated.
Rarefaction curves
Using QIIME we performed rarefaction analysis. The original OTU table was randomly subsampled (rarefied) to create a series of subsampled OTU tables. Alpha diversity was calculated on each sample using the OTU table and a variety of metrics (PD whole tree, observed species, etc). The results of the alpha diversity were collated into a single file and the number of species identified for each sample versus the depth of subsampling was plotted.
Phylogenic Analysis
Multiple alignments were created for OTU sequences that were found in murine feces or in the mouse food. Sequences were obtained using the accession numbers in the dendrograms. Multiple alignments were performed on these sequences using Clustal W2 (35) with a GAP open penalty of 5 and gap extension penalty of 1. Distances from the multiple alignments were then analyzed using Unweighted Pair Group Method with Arithmetic Mean (UPGMA) clustering creating dendrograms which were populated at each node with the distance between each pair wise relationship.
Real Time PCR
Tissue samples from the proximal and distal colon were isolated and homogenized. RNA was isolated by using RNeasy Mini Kit (Qiagen) and reverse transcribed. Real-time RT-PCR analyses were done on the Applied Biosystems 7500 Fast Real-Time PCR System with the SYBR Green PCR kit as instructed by the manufacturer (Applied Biosystems). The amount of mRNA was normalized to the amount of rpl32 mRNA, a housekeeping control gene that does not change substantially during gut inflammation which we have previously used for this purpose (27) , (29) . Samples were analyzed for gene expression using the following primers:
Statistics Unpaired-Student's t-test was used to evaluate differences between experimental groups. Multiple groups (4-10 mice/group) were analyzed by one way analysis of variance (one way ANOVA) followed by a Tukey multiple comparisons test. Statistical analysis was performed using GraphPad Prism software (Graphpad Software Inc., San Diego, CA).
Study of medically refractory ulcerative colitis
Ulcerative colitis subjects were recruited at the Inflammatory Bowel Disease Center at Cedars-Sinai Medical Center following informed patient consent and Cedars SinaiMedical Center Institutional Review Board approval. Details of UC diagnosis was based on standard clinical, endoscopic, and histological findings; details have been previously described along with details of the definition of medically refractory ulcerative colitis (MRUC) (25) . In brief, MRUC subjects required colectomy for severe disease refractory to medical therapies. For the MRUC group, time from diagnosis to date of colectomy was obtained; for the non-MRUC group time from diagnosis to last follow-up visit was obtained. Demographics for these subjects have been previously published; in general the median follow-up of the non-MRUC group was twice that of time to colectomy of the MRUC group (25) . Healthy controls were obtained from the Cardiovascular Health Study (CHS), a population-based cohort study of risk factors for cardiovascular disease and stroke in adults 65 years of age or older, recruited at four field centers (36, 37) 5,201 predominantly Caucasian individuals were recruited in 1989-1990 from random samples of Medicare eligibility lists, followed by an additional 687 African-Americans recruited in 1992-1993 (total n= 5,888). CHS was approved by the Institutional Review Board at each recruitment site, and subjects provided informed consent for the use of their genetic information. A total of 3208 Caucasian non-IBD control subjects who underwent GWAS were included in these analyses. African-American CHS participants were excluded from analysis due to insufficient number of ethnically-matched cases. Genotyping was performed at the Medical Genetics Institute at Cedars-Sinai Medical Center using the Illumina HumanCNV370 platform (Illumina, San Diego, CA). Five SNPs passing quality control spanned the CLEC7A gene (Supplementary Figure 23A) ; a total of 806 UC subjects with complete CLEC7A genotyping data, MRUC determination, and time to surgery or to last visit and were included in these analyses (MRUC n= 315; non-MRUC n= 491).
The rs2078178-rs16910631 haplotype was identified by loading the SNP data into Haploview v4 and testing for association (Supplementary Figure 23B) . Assignment of haplotypes for final analysis employed PHASE v2.3 (38, 39) . The number of each haplotype assigned is as follows:
Haplotype number assigned  1  AG  430  2  AA  45  3  GG  1314  4 GA 43
The greatest uncertainty in the assignment was when the subject was heterozygous for both markers. These were removed from the analysis.
Haplotypes formed with probability > 0.99 were tested for association with MRUC by logistic regression and Fisher's Exact Test, and for association with time to surgery by fitting with a Cox proportional hazards model (Survival package in R) (40) . Haplotypes listed as "Other combinations" were those that could not be reliably determined (posterior p<0.95). These were not included in the logistic regression or Cox proportional hazards analyses.
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Fig. S3. Fluconazole treatment of mice depletes intestinal fungi.
Mice were treated or not with fluconazole for 2 weeks, and colon sections were stained with a soluble Dectin-1 probe (sDEC-1) and counterstained with DAPI. The soluble Dectin-1 probe (red) binds to abundant luminal fungi in untreated animals, but fluconazole treatment substantially reduces the presence of fungi. -/-mice 4 days after DSS treatment was measured by qPCR and normalized to Rpl32 mRNA. Each symbol represents a different mouse. One of four independent experiments is shown. Error bars, s.d., * P < 0.05, ** P < 0.01. WT and Clec7a -/-mice were given an antibiotic cocktail including fluconazole for 3 weeks, transplanted as indicated (red) with fecal microflora from WT or Clec7a -/-mice and treated with 2.5% DSS for 7 days. (A) To access microflora depletion, feces were collected and plated before and after antibiotic treatment (n=10). (B) Colitis progression and severity were assessed by measuring body weight during treatment, and (C) TNF-α production in the colon on day 11. Each symbol represents a different mouse. One of two independent experiments is shown. Error bars, s.d., * P < 0.05, ** P < 0.01.
Fig. S10. Fecal microflora from Clec7a
-/-mice does not transfer susceptibility to colitis in WT mice. WT mice were given an antibiotic cocktail including fluconazole for 3 weeks, transplanted as indicated (red) with fecal microflora from WT or Clec7a -/-mice and treated with 2.5% DSS for 7 days. (A) Body weight was measured daily. Histology score (B), and production of IL-17 and IFN-γ by LI-LP, and TNF-α production in the colon (C) were determined on day 11. Each symbol represents a different mouse. One of two independent experiments is shown. Error bars, s.d., * P < 0.05, ** P < 0.01.
Fig. S11. Rarefaction curve demonstrating fungal sequence coverage in WT and

Clec7a
-/-mice before and after colitis.
DNA was isolated from feces of WT and Clec7a -/-mice before and after the onset of colitis (n=16) and subjected to Illumina GA sequencing. The curve depicts the number of operational taxonomic units (OTU) observed at different sampling depth where the X axis is the number of ITS1-2 reads and the Y axis is the number of OTUs observed. DNA was isolated from mouse food and murine feces. Fungal microbiome analysis was performed using Roche 454 and Illumina GA sequencing of ITS1-2 rDNA. Pie charts represent taxonomic distribution of 20 most abundant fungal species in murine feces (left pie chart) and in mouse food (right pie chart). Species breakdown for major groups are provided (small pie charts on the left).Red arrows show species present in both mouse food and feces. The left pie chart is the same as in Figure 3A and is included again here for comparison. -/-show changes in the distribution of major fungal genera during colitis. Quantitative analysis of the three major intestinal fungal genera in wild type and Clec7a -/-mice before and after treatment with DSS was performed. Illumina GA data were analyzed and presented as relative percentage of dominant fungal genera (n=16 mice). Error bars, s.d., * P < 0.05, ** P < 0.01.
Fig. S16. Fungal invasion of colonic tissue in Clec7a
-/-mice during colitis.
Colon sections from WT and Clec7a -/-mice before and after colitis were stained with the anti-fungal antibody and counterstained with DAPI. WT and Clec7a -/-mice were supplemented with four doses of C. tropicalis or S. fibuligera, treated with 2.5% DSS for 7 days (beginning on day 7 after the first dose of fungi) and then kept on water for 4 additional days (A). Graph represent body weight in WT and Clec7a -/-mice supplemented or not with C. tropicalis (B) or S. fibuligera (C) (n=4). Weight loss in (B) was significantly greater in Clec7a -/-mice supplemented with C. tropicalis at the peak of disease (days 8 and 9). The production of IL-17 and IFN-γ by LI-LP (D) and MLN (E)T cells were determined by ELISA 4 days after DSS treatment. Each symbol represents a separate mouse. Data represent one of 2 independent experiments. Error bars, s.d., * P < 0.05. Mice were treated as described in Supplementary Figure 18 . The expression of tnfa, Il23a, Il17a, cxcl2 and defa3-defa6 in colons was measured by qPCR and normalized to Rpl32 mRNA (n=3) Data represent one of 2 independent experiments. Error bars, s.d., * P < 0.05, ** P < 0.01. -/-mice were supplemented with four doses (1x10 8 yeast/mouse/dose) of Candida tropicalis (C.trop) or Saccharomycopsis fibuligera (S.fib) according to the schedule shown, and colitis was induced with 2.5% DSS in the drinking water for 7 days followed by 4 days of recovery. Feces were collected before supplementation with respective fungi (NT), or before (C.trop or S.fib) and after (DSS/C.trop or DSS/S.fib) DSS treatment. Feces were analyzed by qPCR for the presence of (B) C. tropicalis or (C) S. fibuligera rDNA before (B and C, left) and after (B and C, right) DSS treatment. Each symbol represents a different mouse. * P < 0.05, ns (not significant). Data represent one of 2 independent experiments. 
